top of page
Asset 3@2x.jpg
Cream, Yellow Orange Modern Aesthetic Podcast New Episode Instagram Post.png

Upon completion of this course the participants will be able to
• Define inflammatory bowel disease (Crohn’s, ulcerative colitis), irritable bowel syndrome (IBS) and celiac disease
• List oral signs and symptoms of gastrointestinal inflammatory conditions
• Compare treatments strategies for IBD, IBS, and celiac disease
• Discuss oral effects of medications used to treat these conditions

Join Our May 22nd
Virtual Live CE

Opt-in emails from Dental Hygiene Spark, LLC, BioGaia, CloSys, and Cloud Dentistry.

Continuing Education Credits issued may not apply towards license renewal in all state/provinces. It is the responsibility of each participant to verify the requirements of his/her state/provincial licensing board(s) and to self-report their continuing education hours earned

Thank you for registering.

An email will be sent shortly with a webinar link.

Two million Americans are diagnosed with inflammatory bowel disease (IBD)—Crohn’s & ulcerative colitis—and the number is increasing by 70 thousand new cases annually. At the same time, about 10-20% of the adult population has irritable bowel syndrome (IBS). During this course, participants will define IBD, IBS and celiac disease and discuss the differences of these conditions, prognosis and methods of treatment. The participants will compare oral signs of these conditions and assess risks for oral diseases. The participants will also evaluate the effects of medications, need for medical consultation, modifications to routine dental care and oral hygiene instructions for patients with these conditions.

bottom of page